-
Tocilizumab, sold
under the
brand name
Actemra among others, is an
immunosuppressive drug, used for the
treatment of
rheumatoid arthritis,
systemic juvenile...
-
dexamethasone (a steroid,
which reduces inflammation)
Intravenous immunoglobulin Tocilizumab (an anti-inflammatory)
Anakinra (an anti-inflammatory) The following...
-
beneficial or not as it has not been studied.
Injections of
tocilizumab may also be used.
Tocilizumab is a
humanized antibody that
targets the interleukin-6...
-
negating the
effect of
drugs intended to
activate the
immune system.
Tocilizumab, an anti-IL-6
monoclonal antibody, was FDA
approved for steroid-refractory...
-
cyclophosphamide therapy has failed. Furthermore,
should DMARDs fail,
tocilizumab can be used for
tumor necrosis factor (TNF)
inhibitor treatments in NICE...
- hydroxychloroquine, penicillamine, azathioprine, methotrexate, etanercept, anakinra,
tocilizumab, cyclophosphamide, adalimumab, rituximab, and infliximab.
Newer medications...
- also be used.
There is
tentative evidence for
selenium in mild disease.
Tocilizumab, a drug used to
suppress the
immune system, has also been
studied as...
- rheumatica.
Remitting seronegative symmetrical synovitis with
pitting edema Tocilizumab "Polymyalgia Rheumatica".
National Institute of
Arthritis and Musculoskeletal...
- [citation needed]
Promising results are
achieved with
mycophenolate and
tocilizumab. If
treatment is not kept to a high standard, long-term
damage or death...
-
prostate cancer.
Tocilizumab was
jointly developed by
Osaka University and Chugai, and was
licensed in 2003 by Hoffmann-La Roche.
Tocilizumab was approved...
